Rosemont Pharmaceuticals Overview
- Founded
-
1967
- Status
-
Private
- Employees
-
166
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
4
- Investments
-
1
Rosemont Pharmaceuticals General Information
Description
Manufacturer and supplier of oral liquid formulations of off-patent and solid-dose pharmaceutical products intended for patients with swallowing difficulties. The company provides liquid and solid medications also provides medicines for anesthesia, cardiovascular system, central nervous system, endocrine system, gastrointestinal system, infections, malignant disease and immunosuppression, musculoskeletal and joint disease.
Contact Information
Website
www.rosemontpharma.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Primary Office
- Rosemont House, Yorkdale Industrial Park
- Braithwaite Street
- Leeds LS11 9XE
- England, United Kingdom
+44 0113 000 0000
Rosemont Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Rosemont Pharmaceuticals Patents
Rosemont Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3168005-A1 | Liquid pharmaceutical composition of clonidine | Pending | 20-Jul-2021 | 0000000000 | |
| EP-4122450-A1 | Liquid pharmaceutical composition of clonidine | Pending | 20-Jul-2021 | 0000000000 | 0 |
| GB-202110420-D0 | Liquid pharmaceutical composition of clonidine | Inactive | 20-Jul-2021 | 0000000000 | |
| US-20220016074-A1 | Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability | Pending | 21-Nov-2018 | 00000000 | |
| EP-3883546-A1 | Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability | Pending | 21-Nov-2018 | A61K31/36 |
Rosemont Pharmaceuticals Executive Team (7)
Rosemont Pharmaceuticals Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000000 000000 | Rosemont Pharmaceuticals | Chief Executive Officer & Board Member | 000 0000 |
| 0000 0000000 | Rosemont Pharmaceuticals | Operations Director, Site Leader & Board Member | 000 0000 |
| 0000 00000000 | Rosemont Pharmaceuticals | Chairman | 000 0000 |
Rosemont Pharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Rosemont Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Rosemont Pharmaceuticals Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000 000 | 25-Nov-2021 | 0000000000 | Buildings and Property | 000000 00 |